跳至主要内容
临床试验/CTRI/2024/08/072896
CTRI/2024/08/072896尚未招募Unknown

Prospective Single Arm Open Label case study to evaluate the Efficacy of Low dose oral minoxidil tablets in treatment of Androgenetic Alopecia

DrPSMohanasundari1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年8月30日最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
assess the hair regrowth by measuring hair desnsity and hair count by dermoscopy/phototrichogram.

研究概览

简要总结

Patients satisfying the criteria were included in the study and demographic details will be recorded. A detailed clinical history , a complete general examination, systemic examination and dermatological examination will be made. Assessing the severity of hairloss in the patient by standardized hairloss assessment scales like Norwood Hamilton scale for males and Ludwig scale for females. Digital photographs will be taken. Appropriate blood test complete blood count, liver function test, renal function test Thyroid function test,,ECG will be taken. Male patient with patterned hair loss will be given oral minoxidil 2.5mg OD and female patient with patterend hairloss will be given oral minoxidil 1.25mg OD for a period of 24 weeks , follow up of the patient by every 4weeks once .

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)
性别
All

入选标准

  • Patient who give consent to the study and followup Patient with age group more than 18 years of both sex Patient diagnosed with Androgenetic alopecia male or female patterned hair loss (having grade I to V Norwood Hamilton scale , I to III Ludwigs scale ) Patient who allows to take photographs.

排除标准

  • Patient age less than 18 years of age.
  • Patients not willing to participate in this study.
  • Patient with comorbities such as hypertension , Cardiovascular disorder , renal disease , liver disease, thyroid disorder, hyperandrogenism (PCOS )or another significant Medical condition that may contraindicate the use of minoxidil.
  • Patient with diagnosis other than male and female patterend hair loss Androgenetic alopecia.
  • Patient on treatment with topical minoxidil or any other treament for hairloss.
  • Patient with known hypersensitivity or allergy to Minoxidil .
  • Patient taking medication that interfere with minoxidil such as beta blockers , vasodilators .
  • Patient who have participated in another clinical study involving hair growth treatments within past three months.
  • Pregnancy and lactating mother.
  • Patient with unrealistic expectation.

结局指标

主要结局

assess the hair regrowth by measuring hair desnsity and hair count by dermoscopy/phototrichogram.

时间窗: 6 months

次要结局

  • compare the effects of low dose oral minoxidil in male and female pattern hairloss.(6 months)

研究者

发起方
DrPSMohanasundari
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr P S Mohanasundari

Government Stanley Medical College and Hospital

研究点 (1)

Loading locations...

相似试验